Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials

Podobne zapisy

• Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
  od: Clara Malattia, i wsp.
  Wydane: (2020-09-01)
• PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
  od: Malattia, C, i wsp.
  Wydane: (2013)
• Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
  od: Buoncompagni Antonella, i wsp.
  Wydane: (2007-12-01)
• Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
  od: Palmisani, Elena, i wsp.
  Wydane: (2007)
• Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial
  od: Brunner, Hermine I., i wsp.
  Wydane: (2021)